Short-chain fatty acids in the context of Parkinson’s disease

by Judith Metzdorf, Lars Tönges
Published 2021-01-01

Antibody-based immunotherapies for Parkinsonian syndromes

by Lars Tonges, Maria Angela Samis Zella
Published 2019-01-01

Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients

by Daniel Richter, Dirk Woitalla, Dirk Woitalla, Siegfried Muhlack, Ralf Gold, Ralf Gold, Lars Tönges, Lars Tönges, Christos Krogias
Published 2018-08-01

Letter to the editor: risk comorbidities of COVID-19 in Parkinson’s disease patients in Germany

by Daniel Richter, Dirk Bartig, Christos Krogias, Lars Tönges
Published 2020-08-01

Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease

by Friederike Ostendorf, Judith Metzdorf, Ralf Gold, Aiden Haghikia, Lars Tönges
Published 2020-05-01

Building a Parkinson-Network–Experiences from Germany

by Marlena van Munster, Lars Tönges, Kai F. Loewenbrück, Tobias Warnecke, Carsten Eggers
Published 2020-08-01

Parkinson’s Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement

by Elke Hartelt, Raphael Scherbaum, Manuel Kinkel, Ralf Gold, Siegfried Muhlack, Lars Tönges
Published 2020-06-01

Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein

by Katalin Barkovits, Niels Kruse, Andreas Linden, Lars Tönges, Kathy Pfeiffer, Brit Mollenhauer, Katrin Marcus
Published 2020-02-01

Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany

by Raphael Scherbaum, Eun-Hae Kwon, Daniel Richter, Dirk Bartig, Ralf Gold, Christos Krogias, Lars Tönges
Published 2021-09-01

Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany

by Daniel Richter, Simon Faissner, Dirk Bartig, Lars Tönges, Kerstin Hellwig, Ilya Ayzenberg, Christos Krogias, Ralf Gold
Published 2021-08-01

The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germ...

by Daniel Richter, Simon Faissner, Dirk Bartig, Lars Tönges, Kerstin Hellwig, Ilya Ayzenberg, Christos Krogias, Ralf Gold
Published 2021-07-01

Emerging Immunotherapies for Parkinson Disease

by Samis M. A. Zella, Judith Metzdorf, Emine Ciftci, Friederike Ostendorf, Siegfried Muhlack, Ralf Gold, Lars Tönges
Published 2018-12-01

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease

by Maria Angela Samis Zella, Judith Metzdorf, Friederike Ostendorf, Fabian Maass, Siegfried Muhlack, Ralf Gold, Aiden Haghikia, Lars Tönges
Published 2019-01-01

Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis

by Ilya Ayzenberg, Ilya Ayzenberg, Gisa Ellrichmann, Christoph Schroeder, Lars Tönges, Anja Klasing, Vaia Pappa, Wolfgang Brück, Ralf Gold
Published 2019-08-01

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017

by Maria Angela Samis Zella, Dirk Bartig, Lennard Herrmann, Gesine Respondek, Günter Höglinger, Ralf Gold, Dirk Woitalla, Christos Krogias, Lars Tönges
Published 2020-07-01

miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain Neurons

by Anna-Elisa Roser, Lucas Caldi Gomes, Rashi Halder, Gaurav Jain, Fabian Maass, Lars Tönges, Lars Tatenhorst, Mathias Bähr, André Fischer, Paul Lingor
Published 2018-06-01

A Propagated Skeleton Approach to High Throughput Screening of Neurite Outgrowth for In Vitro Parkinson’s Disease Modelling

by Justus Schikora, Nina Kiwatrowski, Nils Förster, Leonie Selbach, Friederike Ostendorf, Frida Pallapies, Britta Hasse, Judith Metzdorf, Ralf Gold, Axel Mosig, Lars Tönges
Published 2021-04-01

AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo

by Kim-Ann Saal, Jan C. Koch, Lars Tatenhorst, Éva M. Szegő, Vinicius Toledo Ribas, Uwe Michel, Mathias Bähr, Lars Tönges, Paul Lingor
Published 2015-01-01

Structured Care and Self-Management Education for Persons with Parkinson’s Disease: Why the First Does Not Go without the Second—Systematic Review, Experiences and Implementation C...

by Jenny Tennigkeit, Tim Feige, Maria Haak, Carina Hellqvist, Ümran S. Seven, Elke Kalbe, Jaqueline Schwarz, Tobias Warnecke, Lars Tönges, Carsten Eggers, Kai F. Loewenbrück
Published 2020-08-01

Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson’s Disease

by Tobias Hegelmaier, Marco Lebbing, Alexander Duscha, Laura Tomaske, Lars Tönges, Jacob Bak Holm, Henrik Bjørn Nielsen, Sören G. Gatermann, Horst Przuntek, Aiden Haghikia
Published 2020-02-01